Higher plasma lopinavir concentrations are associated with a moderate rise in cholestasis markers in HIV-infected patients.
about
Pros and cons of the tuberculosis drugome approach--an empirical analysisUtility of therapeutic drug monitoring in the management of HIV-infected pregnant women in receipt of lopinavirGenetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1Recurrence of another hepatitis B virus escape mutant comes back in a patient infected with HIV and low CD4+ count.
P2860
Higher plasma lopinavir concentrations are associated with a moderate rise in cholestasis markers in HIV-infected patients.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Higher plasma lopinavir concen ...... kers in HIV-infected patients.
@en
Higher plasma lopinavir concen ...... kers in HIV-infected patients.
@nl
type
label
Higher plasma lopinavir concen ...... kers in HIV-infected patients.
@en
Higher plasma lopinavir concen ...... kers in HIV-infected patients.
@nl
prefLabel
Higher plasma lopinavir concen ...... kers in HIV-infected patients.
@en
Higher plasma lopinavir concen ...... kers in HIV-infected patients.
@nl
P2093
P50
P356
P1476
Higher plasma lopinavir concen ...... rkers in HIV-infected patients
@en
P2093
Anna Danise
Armando Soldarini
Elisabetta Carini
Fernanda Dorigatti
Gianluca Gentilini
Laura Galli
P304
P356
10.1093/JAC/DKI314
P407
P577
2005-09-05T00:00:00Z